Clinicopathological and Immunohistochemical Characteristics of Esophageal Carcinosarcoma

Background: Esophageal carcinosarcoma is a very rare neoplasm and its clinicopathological characteristics and the prognostic factors that influence the clinical outcome of the patient remain a matter of controversy. Patients and Methods: Twenty patients with esophageal carcinosarcoma were referred t...

Full description

Saved in:
Bibliographic Details
Published inAnticancer research Vol. 29; no. 8; pp. 3375 - 3380
Main Authors SANO, Akihiko, SAKURAI, Shinji, SANO, Takaaki, HOSOYA, Yoshinori, ENOMOTO, Takehiko, KANDA, Tatsuo, AJIOKA, Yoichi, OYAMA, Tetsunari, KUWANO, Hiroyuki, KATO, Hiroyuki, SAKAI, Makoto, TANAKA, Naritaka, INOSE, Takanori, SAITO, Kana, SOHDA, Makoto, NAKAJIMA, Masanobu, SAKAMOTO, Kazuha
Format Journal Article
LanguageEnglish
Published Attiki International Institute of Anticancer Research 01.08.2009
Subjects
Online AccessGet full text
ISSN0250-7005
1791-7530
1791-7530

Cover

Abstract Background: Esophageal carcinosarcoma is a very rare neoplasm and its clinicopathological characteristics and the prognostic factors that influence the clinical outcome of the patient remain a matter of controversy. Patients and Methods: Twenty patients with esophageal carcinosarcoma were referred to our institutions. Tissue blocks were reviewed and sections containing both carcinomatous and sarcomatous components were stained for epithelial and mesenchymal markers and a proliferating cell marker. The prognosis of the esophageal carcinosarcoma patients was compared with 142 cases of esophageal squamous cell carcinoma. Results: In the carcinomatous component, the expression of cytokeratin, epithelial membrane antigen, vimentin, smooth muscle actin, and S100 were detected in 20, 20, 1, 1, and 1 case, respectively, whereas in the sarcomatous component, expression of these were detected in 4, 2, 18, 15, and 3 cases, respectively. The Ki-67 labeling index of carcinomatous and sarcomatous components was 35.5% and 41.8%, respectively. The 5-year survival rate was not statistically different between squamous cell carcinoma and carcinosarcoma (p=0.219). However, for T1 cases only, carcinosarcoma patients had statistically poorer prognosis than did squamous cell carcinoma patients (p=0.008). Conclusion: The sarcomatous component shows various histological and immunohisto-chemical forms. In comparison with squamous cell carcinoma patients, carcinosarcoma patients had poorer prognosis amongst the T1 cases. For the treatment of esophageal carcinosarcoma, it is important to monitor lymph nodes and be watchful for hematogenous metastasis, as in cases of esophageal squamous cell carcinoma.
AbstractList Esophageal carcinosarcoma is a very rare neoplasm and its clinicopathological characteristics and the prognostic factors that influence the clinical outcome of the patient remain a matter of controversy.BACKGROUNDEsophageal carcinosarcoma is a very rare neoplasm and its clinicopathological characteristics and the prognostic factors that influence the clinical outcome of the patient remain a matter of controversy.Twenty patients with esophageal carcinosarcoma were referred to our institutions. Tissue blocks were reviewed and sections containing both carcinomatous and sarcomatous components were stained for epithelial and mesenchymal markers and a proliferating cell marker. The prognosis of the esophageal carcinosarcoma patients was compared with 142 cases of esophageal squamous cell carcinoma.PATIENTS AND METHODSTwenty patients with esophageal carcinosarcoma were referred to our institutions. Tissue blocks were reviewed and sections containing both carcinomatous and sarcomatous components were stained for epithelial and mesenchymal markers and a proliferating cell marker. The prognosis of the esophageal carcinosarcoma patients was compared with 142 cases of esophageal squamous cell carcinoma.In the carcinomatous component, the expression of cytokeratin, epithelial membrane antigen, vimentin, smooth muscle actin, and S100 were detected in 20, 20, 1, 1, and 1 case, respectively, whereas in the sarcomatous component, expression of these were detected in 4, 2, 18, 15, and 3 cases, respectively. The Ki-67 labeling index of carcinomatous and sarcomatous components was 35.5% and 41.8%, respectively. The 5-year survival rate was not statistically different between squamous cell carcinoma and carcinosarcoma (p=0.219). However, for T1 cases only, carcinosarcoma patients had statistically poorer prognosis than did squamous cell carcinoma patients (p=0.008).RESULTSIn the carcinomatous component, the expression of cytokeratin, epithelial membrane antigen, vimentin, smooth muscle actin, and S100 were detected in 20, 20, 1, 1, and 1 case, respectively, whereas in the sarcomatous component, expression of these were detected in 4, 2, 18, 15, and 3 cases, respectively. The Ki-67 labeling index of carcinomatous and sarcomatous components was 35.5% and 41.8%, respectively. The 5-year survival rate was not statistically different between squamous cell carcinoma and carcinosarcoma (p=0.219). However, for T1 cases only, carcinosarcoma patients had statistically poorer prognosis than did squamous cell carcinoma patients (p=0.008).The sarcomatous component shows various histological and immunohistochemical forms. In comparison with squamous cell carcinoma patients, carcinosarcoma patients had poorer prognosis amongst the T1 cases. For the treatment of esophageal carcinosarcoma, it is important to monitor lymph nodes and be watchful for hematogenous metastasis, as in cases of esophageal squamous cell carcinoma.CONCLUSIONThe sarcomatous component shows various histological and immunohistochemical forms. In comparison with squamous cell carcinoma patients, carcinosarcoma patients had poorer prognosis amongst the T1 cases. For the treatment of esophageal carcinosarcoma, it is important to monitor lymph nodes and be watchful for hematogenous metastasis, as in cases of esophageal squamous cell carcinoma.
Esophageal carcinosarcoma is a very rare neoplasm and its clinicopathological characteristics and the prognostic factors that influence the clinical outcome of the patient remain a matter of controversy. Twenty patients with esophageal carcinosarcoma were referred to our institutions. Tissue blocks were reviewed and sections containing both carcinomatous and sarcomatous components were stained for epithelial and mesenchymal markers and a proliferating cell marker. The prognosis of the esophageal carcinosarcoma patients was compared with 142 cases of esophageal squamous cell carcinoma. In the carcinomatous component, the expression of cytokeratin, epithelial membrane antigen, vimentin, smooth muscle actin, and S100 were detected in 20, 20, 1, 1, and 1 case, respectively, whereas in the sarcomatous component, expression of these were detected in 4, 2, 18, 15, and 3 cases, respectively. The Ki-67 labeling index of carcinomatous and sarcomatous components was 35.5% and 41.8%, respectively. The 5-year survival rate was not statistically different between squamous cell carcinoma and carcinosarcoma (p=0.219). However, for T1 cases only, carcinosarcoma patients had statistically poorer prognosis than did squamous cell carcinoma patients (p=0.008). The sarcomatous component shows various histological and immunohistochemical forms. In comparison with squamous cell carcinoma patients, carcinosarcoma patients had poorer prognosis amongst the T1 cases. For the treatment of esophageal carcinosarcoma, it is important to monitor lymph nodes and be watchful for hematogenous metastasis, as in cases of esophageal squamous cell carcinoma.
Background: Esophageal carcinosarcoma is a very rare neoplasm and its clinicopathological characteristics and the prognostic factors that influence the clinical outcome of the patient remain a matter of controversy. Patients and Methods: Twenty patients with esophageal carcinosarcoma were referred to our institutions. Tissue blocks were reviewed and sections containing both carcinomatous and sarcomatous components were stained for epithelial and mesenchymal markers and a proliferating cell marker. The prognosis of the esophageal carcinosarcoma patients was compared with 142 cases of esophageal squamous cell carcinoma. Results: In the carcinomatous component, the expression of cytokeratin, epithelial membrane antigen, vimentin, smooth muscle actin, and S100 were detected in 20, 20, 1, 1, and 1 case, respectively, whereas in the sarcomatous component, expression of these were detected in 4, 2, 18, 15, and 3 cases, respectively. The Ki-67 labeling index of carcinomatous and sarcomatous components was 35.5% and 41.8%, respectively. The 5-year survival rate was not statistically different between squamous cell carcinoma and carcinosarcoma (p=0.219). However, for T1 cases only, carcinosarcoma patients had statistically poorer prognosis than did squamous cell carcinoma patients (p=0.008). Conclusion: The sarcomatous component shows various histological and immunohisto-chemical forms. In comparison with squamous cell carcinoma patients, carcinosarcoma patients had poorer prognosis amongst the T1 cases. For the treatment of esophageal carcinosarcoma, it is important to monitor lymph nodes and be watchful for hematogenous metastasis, as in cases of esophageal squamous cell carcinoma.
Author YOSHINORI HOSOYA
NARITAKA TANAKA
KAZUHA SAKAMOTO
HIROYUKI KUWANO
MAKOTO SAKAI
TAKANORI INOSE
AKIHIKO SANO
TAKAAKI SANO
TETSUNARI OYAMA
SHINJI SAKURAI
TATSUO KANDA
TAKEHIKO ENOMOTO
MASANOBU NAKAJIMA
HIROYUKI KATO
KANA SAITO
MAKOTO SOHDA
YOICHI AJIOKA
Author_xml – sequence: 1
  givenname: Akihiko
  surname: SANO
  fullname: SANO, Akihiko
  organization: Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan
– sequence: 2
  givenname: Shinji
  surname: SAKURAI
  fullname: SAKURAI, Shinji
  organization: Department of Diagnostic Pathology, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan
– sequence: 3
  givenname: Takaaki
  surname: SANO
  fullname: SANO, Takaaki
  organization: Department of Diagnostic Pathology, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan
– sequence: 4
  givenname: Yoshinori
  surname: HOSOYA
  fullname: HOSOYA, Yoshinori
  organization: Department of Surgery, Jichi Medical University, Tochigi 329-0498, Japan
– sequence: 5
  givenname: Takehiko
  surname: ENOMOTO
  fullname: ENOMOTO, Takehiko
  organization: Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan
– sequence: 6
  givenname: Tatsuo
  surname: KANDA
  fullname: KANDA, Tatsuo
  organization: Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan
– sequence: 7
  givenname: Yoichi
  surname: AJIOKA
  fullname: AJIOKA, Yoichi
  organization: Division of Molecular and Diagnostic Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan
– sequence: 8
  givenname: Tetsunari
  surname: OYAMA
  fullname: OYAMA, Tetsunari
  organization: Department of Diagnostic Pathology, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan
– sequence: 9
  givenname: Hiroyuki
  surname: KUWANO
  fullname: KUWANO, Hiroyuki
  organization: Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan
– sequence: 10
  givenname: Hiroyuki
  surname: KATO
  fullname: KATO, Hiroyuki
  organization: Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan
– sequence: 11
  givenname: Makoto
  surname: SAKAI
  fullname: SAKAI, Makoto
  organization: Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan
– sequence: 12
  givenname: Naritaka
  surname: TANAKA
  fullname: TANAKA, Naritaka
  organization: Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan
– sequence: 13
  givenname: Takanori
  surname: INOSE
  fullname: INOSE, Takanori
  organization: Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan
– sequence: 14
  givenname: Kana
  surname: SAITO
  fullname: SAITO, Kana
  organization: Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan
– sequence: 15
  givenname: Makoto
  surname: SOHDA
  fullname: SOHDA, Makoto
  organization: Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan
– sequence: 16
  givenname: Masanobu
  surname: NAKAJIMA
  fullname: NAKAJIMA, Masanobu
  organization: Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan
– sequence: 17
  givenname: Kazuha
  surname: SAKAMOTO
  fullname: SAKAMOTO, Kazuha
  organization: Department of Diagnostic Pathology, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21797630$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19661359$$D View this record in MEDLINE/PubMed
BookMark eNpFkctKxDAUhoOMOBd9BelGd4W0aZJ2KWXUAcGNgrtyJk2mkVxq0iK-vVFHXf2H_3yc6xotnHfyBK0K3hQ5pwQv0AqXFOccY7pE6xhfMWasqckZWhYNYwWhzQq9tEY7LfwI0-CNP2gBJgPXZztrZ-cHHScvBmm__XaAAGKSIblaxMyrbBv9OMBBfmUhCO18TOItnKNTBSbKi6Nu0PPt9qm9zx8e73btzUM-lKyZcsalqDimVaX6PREM1ymUBAjBCveVKEmaWnEiSwECSiUoU33fcEZl3dNCkQ26_qk7Bv82yzh1VkchjQEn_Rw7xiljqUECL4_gvLey78agLYSP7vcWCbg6AhDTtiqAEzr-cWW6LGcE_3ODPgzvOsguWjAmlSUdhLLp6o6Q9IFPay141Q
ContentType Journal Article
Copyright 2009 INIST-CNRS
Copyright_xml – notice: 2009 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1791-7530
EndPage 3380
ExternalDocumentID 19661359
21797630
ar29_8_3375
Genre Journal Article
GroupedDBID -
23M
53G
55
5GY
5RE
5VS
ABFLS
ADACO
ADBBV
ADBIT
AENEX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
DIK
EBS
EJD
F5P
H13
KQ8
L7B
OK1
P2P
RHF
RHI
SJN
UDS
VRB
X7M
ZGI
---
.55
.GJ
AFFNX
AIZAD
BTFSW
IQODW
W8F
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-h269t-67ec470544fdb3c608544e3a330f0d4c23006f73e2caca2fc56fdd9765e8d51f3
ISSN 0250-7005
1791-7530
IngestDate Fri Jul 11 12:34:10 EDT 2025
Thu Apr 03 06:59:47 EDT 2025
Wed Apr 02 07:24:48 EDT 2025
Tue Nov 23 16:34:11 EST 2021
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Immunohistochemistry
Esophageal carcinosarcoma
Anatomic pathology
Cancerology
survival analysis
Digestive system
Malignant tumor
Survival
Cancer
Spindle cell carcinoma
Esophagus
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-h269t-67ec470544fdb3c608544e3a330f0d4c23006f73e2caca2fc56fdd9765e8d51f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 19661359
PQID 67566705
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_67566705
pubmed_primary_19661359
pascalfrancis_primary_21797630
highwire_smallpub3_ar29_8_3375
PublicationCentury 2000
PublicationDate 2009-08-01
PublicationDateYYYYMMDD 2009-08-01
PublicationDate_xml – month: 08
  year: 2009
  text: 2009-08-01
  day: 01
PublicationDecade 2000
PublicationPlace Attiki
PublicationPlace_xml – name: Attiki
– name: Greece
PublicationTitle Anticancer research
PublicationTitleAlternate Anticancer Res
PublicationYear 2009
Publisher International Institute of Anticancer Research
Publisher_xml – name: International Institute of Anticancer Research
SSID ssj0066983
Score 2.0409255
Snippet Background: Esophageal carcinosarcoma is a very rare neoplasm and its clinicopathological characteristics and the prognostic factors that influence the...
Esophageal carcinosarcoma is a very rare neoplasm and its clinicopathological characteristics and the prognostic factors that influence the clinical outcome of...
SourceID proquest
pubmed
pascalfrancis
highwire
SourceType Aggregation Database
Index Database
Publisher
StartPage 3375
SubjectTerms Aged
Aged, 80 and over
Biological and medical sciences
Biomarkers, Tumor - metabolism
Carcinoma, Squamous Cell - metabolism
Carcinoma, Squamous Cell - mortality
Carcinoma, Squamous Cell - pathology
Carcinosarcoma - metabolism
Carcinosarcoma - mortality
Carcinosarcoma - pathology
Esophageal Neoplasms - metabolism
Esophageal Neoplasms - mortality
Esophageal Neoplasms - pathology
Female
Humans
Immunoenzyme Techniques
Male
Medical sciences
Middle Aged
Neoplasm Invasiveness
Neoplasm Staging
Prognosis
Survival Rate
Tumors
Title Clinicopathological and Immunohistochemical Characteristics of Esophageal Carcinosarcoma
URI http://ar.iiarjournals.org/content/29/8/3375.abstract
https://www.ncbi.nlm.nih.gov/pubmed/19661359
https://www.proquest.com/docview/67566705
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj5swELaye6h6qfpu9lUOvUVUBBsTjmjVFSzaREoTKT0hxw_1sAurPC79A_3bHWPjhShVHxcSOQY7ntF4vmH8DUKfAixgGxORr0QifDLhxGcqFD5s1utIOxTSJMhOabYkt6toNRj87GQt7Xfrz_zH0XMl_yNVaAO56lOy_yBZ91BogO8gX7iChOH6VzI2pJ61rirsbFiT36sPfdQNlTBvCQGuD5iZdUahLmEA9kT_qksKVfUWPmprqR3Dso52g2psRpYYyAWQ0yLP8mI2-ppOZy5Sk-XT2xyaiuU8dRHZLJ_Pvi2LfFSkC9f1Li1mC313YTu2wYfEpb5ZQNqLWvbSGzqzm3dnZ0wbOF5-HATmfbY0pjdOxj6Ap6Brm200xOjgpGNoMTYFVzpSfnxoxAwmBVwUSzPe49c-2PdcNiLbhEk5KfUjT9AJHjfIPC_aDZ3SxLC5tpNuiGbNIB1aaZ1Vy7YgUGUqovwesjSuy-IlemExh5caBXqFBrJ6jZ7d2ayKN2h1RI880CPviB55B3rk1cp70iOvr0dv0fLmy-I6823FDf97SJOdT2PJSQxePFFijTkFf5wQiRnGgQoE4YBXA6piLEPOOAsVj6gSAjzaSE5ENFb4HTqt6kp-QB5mAQ3HgkiABCThAKwFlzxmIo4BBEdkiK7alSu3D-z-HlYIlx1RQIfeepaPhn6lBBANI-JgiD62C1yCTdQvulgl6_22BBBMKfyNIXpv1t3d28rt7E-jn6PnT_p-gU53m728BPdzt75qlOMXBH6MCg
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinicopathological+and+Immunohistochemical+Characteristics+of+Esophageal+Carcinosarcoma&rft.jtitle=Anticancer+research&rft.au=AKIHIKO+SANO&rft.au=SHINJI+SAKURAI&rft.au=HIROYUKI+KATO&rft.au=MAKOTO+SAKAI&rft.date=2009-08-01&rft.pub=International+Institute+of+Anticancer+Research&rft.issn=0250-7005&rft.eissn=1791-7530&rft.volume=29&rft.issue=8&rft.spage=3375&rft_id=info%3Apmid%2F19661359&rft.externalDBID=n%2Fa&rft.externalDocID=ar29_8_3375
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0250-7005&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0250-7005&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0250-7005&client=summon